Entereg is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Merck Sharp & Dohme Corp.. The primary component is Alvimopan.
| Product ID | 67919-020_11d40fc9-6ca5-4259-a7ac-c5e29d7e8513 |
| NDC | 67919-020 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Entereg |
| Generic Name | Alvimopan |
| Dosage Form | Capsule |
| Route of Administration | ORAL |
| Marketing Start Date | 2012-04-16 |
| Marketing Category | NDA / NDA |
| Application Number | NDA021775 |
| Labeler Name | Merck Sharp & Dohme Corp. |
| Substance Name | ALVIMOPAN |
| Active Ingredient Strength | 12 mg/1 |
| Pharm Classes | Opioid Antagonist [EPC],Opioid Antagonists [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |
| Marketing Start Date | 2012-04-16 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA021775 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2012-04-16 |
| Ingredient | Strength |
|---|---|
| ALVIMOPAN | 12 mg/1 |
| SPL SET ID: | 77a67dc6-35d3-48ff-9d18-292d4d442f70 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 67919-020 | Entereg | alvimopan |
| 0591-2312 | Alvimopan | Alvimopan |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() ENTEREG 87123814 not registered Live/Pending |
Merck Sharp & Dohme Corp. 2016-08-02 |
![]() ENTEREG 87123810 not registered Live/Pending |
Merck Sharp & Dohme Corp. 2016-08-02 |
![]() ENTEREG 78449167 not registered Dead/Abandoned |
ADOLOR CORPORATION 2004-07-12 |
![]() ENTEREG 78432539 not registered Dead/Abandoned |
ADOLOR CORPORATION 2004-06-09 |
![]() ENTEREG 77549901 3591151 Dead/Cancelled |
Adolor Corporation 2008-08-18 |
![]() ENTEREG 77549881 3615172 Dead/Cancelled |
Adolor Corporation 2008-08-18 |
![]() ENTEREG 76287429 2946371 Live/Registered |
MERCK SHARP & DOHME CORP. 2001-07-19 |